Pan Yan, Zheng Jun-Min, Zhao Hui-Ying, Li Ying-Jian, Xu Hui, Wei Gang
Department of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Acta Pharmacol Sin. 2002 Nov;23(11):1051-6.
To formulate and characterize insulin-loaded adhesive microspheres (MP) and evaluate drug effects of MP with various sizes, 120, 350, and 1000 nm in diameter, in the alloxan-induced diabetic rats.
Insulin-loaded MP were formulated by an ionotropic gelation procedure. Particle size distributions were determined by photon correlation spectroscopy and optical microscopy. The factors that influenced the particle sizes and loading capacity were investigated, and the release properties were assessed in vitro. The hypoglycemic effect was investigated by monitoring the plasma glucose level of the alloxan-induced diabetic rats after oral administration.
All the MPs with three sizes formulated were in the desired size range, and the loading capacity was 15.3 %+/-1.7 % (120 nm), 32.4 %+/-2.4 % (350 nm), and 53.3 %+/-2.7 % (1000 nm) respectively. The particle size also had an influence on the release property of the MPs. Half an hour later, 25 %+/-4 % (120 nm), 18.3 %+/-2.4 % (350 nm), and 8.6 %+/-1.3 % (1000 nm) of insulin were released. MP with different sizes had various degree of hypoglycemic effects after 10 h (P<0.05 vs control insulin solution). The plasma glucose level of 350 nm size particles remarkably decreased 15 h later (P<0.05 vs 120 nm) or 35 h later (P<0.01 vs others). The relative pharmacological availability was 10.2 %+/-0.5 % (120 nm), 14.9 %+/-1.3 % (350 nm), and 7.3 %+/-0.8 % (1000 nm) respectively. Particles of 350 nm showed a comparatively higher availability (P<0.05).
Adhesive CS-MP were helpful in increasing the relative pharmacological bioavailability of insulin, and a distinct advantage of proper particle size helped to increase the drug effects.
制备并表征载胰岛素黏附微球(MP),并评估直径为120、350和1000 nm的不同尺寸MP在四氧嘧啶诱导的糖尿病大鼠中的药物效果。
通过离子凝胶法制备载胰岛素MP。采用光子相关光谱法和光学显微镜测定粒径分布。研究影响粒径和载药量的因素,并体外评估释放特性。通过监测口服给药后四氧嘧啶诱导的糖尿病大鼠的血糖水平来研究降血糖效果。
制备的三种尺寸的所有MP均在所需尺寸范围内,载药量分别为15.3%±1.7%(120 nm)、32.4%±2.4%(350 nm)和53.3%±2.7%(1000 nm)。粒径也对MP的释放特性有影响。半小时后,分别释放了25%±4%(120 nm)、18.3%±2.4%(350 nm)和8.6%±1.3%(1000 nm)的胰岛素。10小时后,不同尺寸的MP有不同程度的降血糖作用(与对照胰岛素溶液相比,P<0.05)。15小时后,350 nm尺寸颗粒的血糖水平显著降低(与120 nm相比,P<0.05),或35小时后(与其他颗粒相比,P<0.01)。相对药理利用率分别为10.2%±0.5%(120 nm)、14.9%±1.3%(350 nm)和7.3%±0.8%(1000 nm)。350 nm的颗粒显示出相对较高的利用率(P<0.05)。
黏附性壳聚糖微球有助于提高胰岛素的相对药理生物利用度,合适粒径的明显优势有助于增强药物效果。